Paul S. Zygielbaum

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.

C8 MediSensors, Inc. creates an innovative optical technology platform for non-invasive concentration measurement of substances in the human body to diagnose and support treatment of major diseases and to help maintain health. It develops HG1-c, a non-invasive continuous glucose monitoring product for diabetics; and optical glucose monitor, an adjunct investigational device to measure glucose trans-dermally. The company was founded in December 2003 by Robert McNamara and Paul Zygielbaum and is headquartered in San Jose, CA.